ovarian neoplasm
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
We analysed the role of germline EMSY variation in breast/ovarian cancer predisposition.
|
28738860 |
2017 |
ovarian neoplasm
|
0.070 |
GeneticVariation
|
disease |
LHGDN |
The remarkable clinical overlap between sporadic EMSY amplification and familial BRCA2 deletion implicates a BRCA2 pathway in sporadic breast and ovarian cancer.
|
14651845 |
2003 |
ovarian neoplasm
|
0.070 |
GeneticVariation
|
disease |
LHGDN |
We used a genetic association study design to determine if common genetic variation (frequency > or = 5%) in EMSY was associated with breast or ovarian cancer risk in the British population.
|
16029503 |
2005 |
Eczema
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, the IL1RL1, HLA, IL13 and C11orf30 regions are overlapping susceptibility loci among atopic dermatitis and asthma or allergic rhinitis.
|
23439055 |
2013 |
Eczema
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Variants in a locus near chromosome 11 open reading frame 30 (C11orf30) and leucine-rich repeat containing 32 (LRRC32), which was previously associated with atopic dermatitis and eczema, were also strongly associated with both phenotypes (rs2155219; P(grass) = 9.4 × 10(-9); P(AR) = 3.8 × 10(-8)).
|
22036096 |
2011 |
Malignant neoplasm of prostate
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
A total of nine non-coding variants on 11q13.5 predispose men to prostate cancer (PrCa). rs200331695 within the EMSY intron is associated with aggressive PrCa and two high linkage disequilibrium (LD) groups of single-nucleotide polymorphisms (SNPs) in the intergenic region are associated with PrCa death.
|
27113481 |
2016 |
Malignant neoplasm of prostate
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to screen EMSY for sequence variants and to evaluate its association with the risk of prostate cancer.
|
21064104 |
2011 |
Malignant neoplasm of prostate
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Correlated intronic SNPs rs10899221 and rs72944758 formed with other EMSY variants common and rare haplotypes that were associated with increased risk (P=4.0 × 10(-4)) and decreased risk (P=0.01) of PrCa, respectively.
|
23830236 |
2013 |
Crohn Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Three CD susceptibility loci were independently associated with surgery within 5 years (IL12B, IL23R, and C11orf30).
|
23665963 |
2013 |
Crohn Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Colon-only CD (n = 228) was compared with healthy controls: three of six UC SNPs (in MST1, HLA-DRA, and IL-23R) and 11 of 34 CD SNPs: in IRGM, NOD2 (rs2066845), CCNY, MST1, IL23R, PTPN22, C11orf30, ZNF365, PTPN2, PSMG1, and rs1456893 were significantly associated.
|
21830272 |
2011 |
Breast Cancer, Familial
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
|
28738860 |
2017 |
Allergic rhinitis (disorder)
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, the IL1RL1, HLA, IL13 and C11orf30 regions are overlapping susceptibility loci among atopic dermatitis and asthma or allergic rhinitis.
|
23439055 |
2013 |
Allergic rhinitis (disorder)
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Both rs7130588_AG and rs7927894_CT genotypes in EMSY region were associated with a significantly increased risk of AR (1.75-fold and 1.50-fold) compared to the AA and CC genotypes, respectively, specific to moderate-to-severe AR.
|
30170133 |
2018 |
IgE-mediated food allergy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We found FLG, HLA, IL10, IL13, as well as some evidence for other variants (SPINK5, SERPINB and C11orf30) that are associated with food allergy.
|
30835860 |
2019 |
Thyroid Neoplasm
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
Absence of allelic imbalance involving EMSY, CAPN5, and PAK1 genes in papillary thyroid carcinoma.
|
18787380 |
2008 |
Breast Neoplasms, Male
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Considering the relevant role of BRCA2 in MBC, we aimed at investigating the role of EMSY gene copy number variations in male breast tumors.
|
27628328 |
2016 |
pricking of skin
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We found that the 10 loci associate with sensitization to different allergens in a nonspecific manner and that one in particular, C11orf30-rs2155219, doubles the risk of poly-sensitization (specific IgE/4 allergens: OR = 1.81, 95% CI 0.80-4.24; skin prick test/4+ allergens: OR = 2.27, 95% CI 1.34-3.95).
|
25546184 |
2015 |
Dermatitis and eczema
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Variants in a locus near chromosome 11 open reading frame 30 (C11orf30) and leucine-rich repeat containing 32 (LRRC32), which was previously associated with atopic dermatitis and eczema, were also strongly associated with both phenotypes (rs2155219; P(grass) = 9.4 × 10(-9); P(AR) = 3.8 × 10(-8)).
|
22036096 |
2011 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
CTD_human |
Here, we investigate the prognostic significance of CCND1 and EMSY amplification in a large series of breast carcinomas and in BRCA1 and BRCA2 mutation positive breast cancers.
|
19636701 |
2010 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
EMSY is located in the breast cancer-associated chromosomal region 11q13.
|
28738860 |
2017 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
As EMSY is located on 11q13 in proximity to CCND1, an established breast cancer oncogene, we also examined the amplification of CCND1 in the same tumor cohort.
|
21327470 |
2011 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
Compared to female breast cancers, EGFR (p = 0.005) and CCND1 (p = 0.041) copy number gain was more often seen in male breast cancer, while copy number gain of EMSY (p = 0.004) and CPD (p = 0.001) and amplification in general was less frequent.
|
22527098 |
2012 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
Altogether, these results suggest a pathway underlying the role of EMSY in breast cancer and uncover potential diagnostic and therapeutic targets in sporadic breast cancer.
|
24582497 |
2014 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
Genetic alterations of CCND1 and EMSY in breast cancers.
|
18393977 |
2008 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
EMSY links breast cancer gene 2 to the 'Royal Family'.
|
15318925 |
2004 |